is Chairman and CEO of Center for Automation in Nanobiotech
(CAN) -- created in 2004 through the collaboration of private
funds. CAN as a private company focuses on investigation
of new paradigms for innovation in systems and automation
design. CAN main thrust and aim is the development of commercial
nanobiotechnology systems and devices that may benefit people
around the globe with biomedical engineering advances.
a CEO and Research Scientist, Cavalcanti has participated
in several joint work collaborations for the fast development
of Nanotechnology and Biomolecular Engineering Automation.
His research activities address various approaches to designing
effective nanorobotics and nanosystems automation. He has
been also developing works on several research projects
related to autonomous systems, scientific visualization
and physically based simulation. Among other projects, he
is also working through the publication of two new books
in Nanorobotics, and preparing to commercialize the software
Nanorobot Control Design (NCD) as a valuable tool for Nanotechnologists,
Engineers, and Machine Designers.
is a contributor of ASME serving as reviewer of distinct
publications. He is a IEEE Member since 2002.
© 2004- 2005 Adriano